Summary
Diflunisal is a nonsteroidal anti-inflammatory drug that is poorly soluble in water. The present study describes the formulation of solid dispersions of the drug designed to increase its solubility. X-ray diffraction and DSC were used to examine the physico-chemical characteristics of solid dispersions of diflunisal and polyvinylpyrrolidone (PVP) prepared by the solvent method, using percentage proprtional compositions ranging from 20:80 to 50:50.
X-ray diffraction analysis detected that diflunisal is present in solid dispersions in crystalline or amorphous state depending on the PVP content.
The thermal behavior of diflunisal observed in the DSC curves of solid dispersion systems, was attributed to a solid-state interaction.
The increased release of the PVP-drug dispersion as compared to the PVP-drug physical mixture was attributed to the formation of a complex resulting from the interaction of the drug and the polymer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Simonelli A.P., Mehta S.C. and Higuchi W.I. (1969).Dissolution rates of high energy polyvinylpyrrolidone-sulphathiazole coprecipitates. J. Pharm. Sci., 58, 538–549.
Corrigan O.I., Timoney R.F. (1975).The influence of polyvinylpyrrolidone on the dissolution and bioavailability of hydrochlorothiazide. J. Pharm. Sci. 28: 703–706.
Simonelli A.P., Mehta S.C. and Higuchi W.I. (1976).Dissolution rates of high energy sulphathiazole povidone coprecipitates II. Characteristics of form of drug controlling its dissolution rate via solubility studies. J. Pharm. Sci., 65, 355–361.
Corrigan O.I., Farvar M.A. and Higuchi W.I. (1980).Drug membrane transport enhancement using high energy drug polyvinylpirrolidone coprecipitates. Int. J. Pharm., 5, 229–238.
Chiou W.L., Riegelman S. (1971).Pharmaceutical application of solid dispersions systems. J. Pharm. Sci. 60:1281–1303.
Shefter E. and Cheng K.C. (1980).Drugpolyvinylpyrrolidone dispersions. A differential scanning calorimetric study. Int. J. Pharm., 6, 179–182.
Sekikawa H., Fujiwara J., Nagamma T., Nakano M. and Arita T. (1979).Dissolution behavours and gastrointestinal absorption of phenytoin in phenytoinpolyvinylpyrrolidone coprecipitate. Chem. Pharm. Bull., 27, 1223–1230.
Wood J.H., Syarto J.E., Letterman H. (1965).Improved holder for intrinsic dissolution rate studies. J. Pharm. Sci. 54: 1068.
Martinez-Oharriz M.C., Martin C., Goñi M.M., Rodriguez-Espinosa C., Tros de Ilarduya-Apaolaza M.C. and S‡nchez M. (1994).Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form. J. Pharm. Sci. 83:174–177.
Bettinetti D. and Mura P. (1994).Dissolution properties of naproxen in combinations with polyvinylpyrrolidone. Drug. Dev. Ind. Pharm., 20(8), 1353–1366.
Bettinetti D., Mura P., Giordano F. and Setti M. (1991).Thermal behaviour and physicochemical properties of naproxen in mixture with polyvinylpyrrolidone. Thermochim. Acta, 199, 165–171.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rodríguez-Espinosa, C., Martínez-Ohárriz, M.C., Martín, C. et al. Dissolution kinetics for coprecipitates of diflunisal with PVP K30. European Journal of Drug Metabolism and Pharmacokinetics 23, 109–112 (1998). https://doi.org/10.1007/BF03189324
Issue Date:
DOI: https://doi.org/10.1007/BF03189324